0
Skip to Content
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Folder: Letters
Back
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
Folder: History of Harm
Back
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Patients
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Support Us
Back
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report

Categories: All Articles • Nanoparticles • Dechelation • Cellular + Mito Dysfunction • GDD/Toxicity • Fibrosis • Other Disease • Chemistry • Heavy Metal Toxicity • Treatment Options • Water Contamination • Other Gd Uses • Pediatrics • Chelators

Anthropogenic gadolinium in the Tone River (Japan): an update showing a 7.7-fold increase from 1996 to 2020 (2024).
Water Contamination Kate 5/24/24 Water Contamination Kate 5/24/24

Anthropogenic gadolinium in the Tone River (Japan): an update showing a 7.7-fold increase from 1996 to 2020 (2024).

Read More
Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids (Dec 2023).
Cellular/Mitochondria dysfunction, Other Gd Uses, Chemistry, Water Contamination, GDD/Toxicity, Other Disease, Heavy Metal Toxicity Bridget Belo 12/25/23 Cellular/Mitochondria dysfunction, Other Gd Uses, Chemistry, Water Contamination, GDD/Toxicity, Other Disease, Heavy Metal Toxicity Bridget Belo 12/25/23

Gadolinium Effects on Liposome Fluidity and Size Depend on the Headgroup and Side Chain Structure of Key Mammalian Brain Lipids (Dec 2023).

Read More
Relationship between gadolinium-based MRI contrast agent consumption and anthropogenic gadolinium in the influent of a wastewater treatment plant (June 2023).
Water Contamination Bridget Belo 6/15/23 Water Contamination Bridget Belo 6/15/23

Relationship between gadolinium-based MRI contrast agent consumption and anthropogenic gadolinium in the influent of a wastewater treatment plant (June 2023).

Read More
Toxicity of lanthanide coagulants assessed using four in vitro bioassays (Aug 2021).
Chemistry, Other Gd Uses, Water Contamination Bridget Belo 8/9/21 Chemistry, Other Gd Uses, Water Contamination Bridget Belo 8/9/21

Toxicity of lanthanide coagulants assessed using four in vitro bioassays (Aug 2021).

Read More
Evidence of Anthropogenic Gadolinium in Triangle Area Waters, North Carolina, USA (2021).
Water Contamination Kate 7/8/21 Water Contamination Kate 7/8/21

Evidence of Anthropogenic Gadolinium in Triangle Area Waters, North Carolina, USA (2021).

Read More
Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks (Dec 2020).
GDD/Toxicity, Dechelation, Cellular, Chemistry, Heavy Metal Toxicity, Other Gd Uses, Mito Dysfunction, Water Contamination Bridget Belo 12/7/20 GDD/Toxicity, Dechelation, Cellular, Chemistry, Heavy Metal Toxicity, Other Gd Uses, Mito Dysfunction, Water Contamination Bridget Belo 12/7/20

Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks (Dec 2020).

Read More
Anthropogenic gadolinium in freshwater and drinking water systems
Water Contamination, Chemistry Bridget Belo 5/29/20 Water Contamination, Chemistry Bridget Belo 5/29/20

Anthropogenic gadolinium in freshwater and drinking water systems

Read More
Gadolinium as an Emerging Microcontaminant in Water Resources: Threats and Opportunities (2019).
Water Contamination Kate 1/4/19 Water Contamination Kate 1/4/19

Gadolinium as an Emerging Microcontaminant in Water Resources: Threats and Opportunities (2019).

Read More

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.